Rajiv Chintamani Yeravdekar

Rajiv Chintamani Yeravdekar

Active Director Nominee Director DIN 02183160
DIN 02183160 First appointment Aug 2008 Primary industry Education & Learing
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Aug 2008
Shareholding value •••• Premium profile

About Rajiv Chintamani Yeravdekar

Data last updated:

Rajiv Chintamani Yeravdekar is a Nominee Director at Symbiosis Centre For Entrepreneurship And Innovation (since 2017) and Director at Apical Academic Infrastructure And Communication Private Limited (since 2008). The companies operate in Education & Learing. The 2 current companies with reported revenue have a combined latest revenue of ₹1.31 Cr; the largest is Symbiosis Centre For Entrepreneurship And Innovation at ₹1.30 Cr (FY 2024). Earlier, Rajiv Chintamani Yeravdekar was a Director at Vars Health Private Limited (from 2011).

DIN 02183160
Primary Designation Nominee Director
Industry Education & Learing
First Appointment 05 Aug 2008
Oldest Company Age 18 yrs
Largest company Symbiosis Centre For Entrepreneurship And Innovation · ₹1.30 Cr (FY 2024)
Combined revenue ₹1.31 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director22 Mar 20172016₹1.30 Cr (FY 2024)Active
Director05 Aug 20082008₹1.5 Lakh (FY 2017)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vars Health Private Limited U85100PN2011PTC140328
Director01 Aug 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apical Academic Infrastructure And Communication Private Limited
Symbiosis Centre For Entrepreneurship And Innovation
Vars Health Private Limited
Premium access

Shareholding and investment profile for Rajiv Chintamani Yeravdekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Chintamani Yeravdekar

Rajiv Chintamani Yeravdekar currently holds 2 directorships: Symbiosis Centre For Entrepreneurship And Innovation (Nominee Director, since 22 Mar 2017, revenue ₹1.30 Cr (FY 2024)); Apical Academic Infrastructure And Communication Private Limited (Director, since 05 Aug 2008, revenue ₹1.5 Lakh (FY 2017)).

Rajiv Chintamani Yeravdekar was first appointed on 05 Aug 2008 as Director at Apical Academic Infrastructure And Communication Private Limited. The most recent appointment on record is 22 Mar 2017 at Symbiosis Centre For Entrepreneurship And Innovation.

The 2 current companies of Rajiv Chintamani Yeravdekar that report revenue have a combined latest revenue of ₹1.31 Cr: Symbiosis Centre For Entrepreneurship And Innovation ₹1.30 Cr (FY 2024); Apical Academic Infrastructure And Communication Private Limited ₹1.5 Lakh (FY 2017).

Rajiv Chintamani Yeravdekar held 1 earlier board appointment: Vars Health Private Limited (Director, from 01 Aug 2011).

The current boards of Rajiv Chintamani Yeravdekar's companies include Bhama Venkataramani (Symbiosis Centre For Entrepreneurship And Innovation), Rajani Rajiv Gupte (Symbiosis Centre For Entrepreneurship And Innovation), Ramakrishnan Raman (Symbiosis Centre For Entrepreneurship And Innovation), Sanjivani Shantaram Mujumdar (Symbiosis Centre For Entrepreneurship And Innovation), Sunil Indrasen Shirole (Symbiosis Centre For Entrepreneurship And Innovation), Vidya Rajiv Yeravdekar (Symbiosis Centre For Entrepreneurship And Innovation), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available